These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 34842495)
1. An update on emerging drugs for the treatment of hypercholesterolemia. Nelson AJ; Bubb K; Nicholls SJ Expert Opin Emerg Drugs; 2021 Dec; 26(4):363-369. PubMed ID: 34842495 [TBL] [Abstract][Full Text] [Related]
2. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting. Cziraky MJ; Watson KE; Talbert RL J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279 [TBL] [Abstract][Full Text] [Related]
3. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. Evans M; Roberts A; Davies S; Rees A Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326 [TBL] [Abstract][Full Text] [Related]
4. Management of Hypercholesterolemia, Appropriateness of Therapeutic Approaches and New Drugs in Patients with High Cardiovascular Risk. Agabiti Rosei E; Salvetti M High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):217-30. PubMed ID: 27567901 [TBL] [Abstract][Full Text] [Related]
6. New LDL-cholesterol lowering therapies: pharmacology, clinical trials, and relevance to acute coronary syndromes. Sahebkar A; Watts GF Clin Ther; 2013 Aug; 35(8):1082-98. PubMed ID: 23932550 [TBL] [Abstract][Full Text] [Related]
7. A Clinical Guide to Combination Lipid-Lowering Therapy. Russell C; Sheth S; Jacoby D Curr Atheroscler Rep; 2018 Mar; 20(4):19. PubMed ID: 29516190 [TBL] [Abstract][Full Text] [Related]
8. A reappraisal of the risks and benefits of treating to target with cholesterol lowering drugs. Alla VM; Agrawal V; DeNazareth A; Mohiuddin S; Ravilla S; Rendell M Drugs; 2013 Jul; 73(10):1025-54. PubMed ID: 23754124 [TBL] [Abstract][Full Text] [Related]
9. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ; ; ; Circulation; 2004 Jul; 110(2):227-39. PubMed ID: 15249516 [TBL] [Abstract][Full Text] [Related]
11. Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-Up. Vallejo-Vaz AJ; Robertson M; Catapano AL; Watts GF; Kastelein JJ; Packard CJ; Ford I; Ray KK Circulation; 2017 Nov; 136(20):1878-1891. PubMed ID: 28877913 [TBL] [Abstract][Full Text] [Related]
12. Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia. Banach M; Duell PB; Gotto AM; Laufs U; Leiter LA; Mancini GBJ; Ray KK; Flaim J; Ye Z; Catapano AL JAMA Cardiol; 2020 Oct; 5(10):1124-1135. PubMed ID: 32609313 [TBL] [Abstract][Full Text] [Related]
13. A new reality: achieving cholesterol-lowering goals in clinical practice. Gaw A Atheroscler Suppl; 2002 Apr; 2(4):5-8; discussion 8-11. PubMed ID: 11976071 [TBL] [Abstract][Full Text] [Related]
15. Keep recycling going: New approaches to reduce LDL-C. Klein-Szanto AJP; Bassi DE Biochem Pharmacol; 2019 Jun; 164():336-341. PubMed ID: 30953636 [TBL] [Abstract][Full Text] [Related]
16. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS; Mikhailidis DP Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [TBL] [Abstract][Full Text] [Related]
17. New Drugs for Lowering LDL-Cholesterol. Bădescu C; Rezuş E; Bădescu L; Dima N; Rezuş C Rev Med Chir Soc Med Nat Iasi; 2016; 120(3):485-90. PubMed ID: 30044561 [TBL] [Abstract][Full Text] [Related]
18. Achieving optimal lipid goals in patients with coronary artery disease. Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526 [TBL] [Abstract][Full Text] [Related]
19. Bempedoic acid plus ezetimibe fixed-dose combination in patients with hypercholesterolemia and high CVD risk treated with maximally tolerated statin therapy. Ballantyne CM; Laufs U; Ray KK; Leiter LA; Bays HE; Goldberg AC; Stroes ES; MacDougall D; Zhao X; Catapano AL Eur J Prev Cardiol; 2020 Apr; 27(6):593-603. PubMed ID: 31357887 [TBL] [Abstract][Full Text] [Related]
20. Targeting PCSK9 as a promising new mechanism for lowering low-density lipoprotein cholesterol. Della Badia LA; Elshourbagy NA; Mousa SA Pharmacol Ther; 2016 Aug; 164():183-94. PubMed ID: 27133571 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]